Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1954 1
1966 1
1967 1
1970 1
1971 1
1972 3
1973 2
1974 12
1975 3
1976 8
1977 4
1978 5
1979 7
1981 4
1982 2
1983 1
1984 4
1985 6
1986 16
1987 16
1988 15
1989 23
1990 23
1991 27
1992 30
1993 27
1994 39
1995 35
1996 37
1997 38
1998 51
1999 65
2000 65
2001 89
2002 89
2003 110
2004 134
2005 177
2006 172
2007 239
2008 275
2009 361
2010 421
2011 473
2012 574
2013 630
2014 684
2015 743
2016 658
2017 675
2018 690
2019 692
2020 803
2021 843
2022 785
2023 735
2024 222

Text availability

Article attribute

Article type

Publication date

Search Results

10,607 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Kichol
Page 1
Dysautonomia: A Forgotten Condition - Part 1.
Rocha EA, Mehta N, Távora-Mehta MZP, Roncari CF, Cidrão AAL, Elias Neto J. Rocha EA, et al. Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420. Arq Bras Cardiol. 2021. PMID: 33886735 Free PMC article. English, Portuguese.
There is no cure for most types of Dysautonomia at a late stage. NOH patients can progress with supine hypertension in more than 50% of the cases, representing a major therapeutic challenge. ...There is no cure for most types of Dysautonomia at a late stage. 11. NOH
There is no cure for most types of Dysautonomia at a late stage. NOH patients can progress with supine hypertension in more than 50% …
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H. Gibbons CH, et al. J Neurol. 2017 Aug;264(8):1567-1582. doi: 10.1007/s00415-016-8375-x. Epub 2017 Jan 3. J Neurol. 2017. PMID: 28050656 Free PMC article. Review.
Due to the frequency of nOH in the aging population, clinicians need to be well informed about its diagnosis and management. To date, studies of nOH have used different outcome measures and various methods of diagnosis, thereby preventing the generation of evidence- …
Due to the frequency of nOH in the aging population, clinicians need to be well informed about its diagnosis and management. To date, …
Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.
Idiaquez JF, Idiaquez J, Casar JC, Biaggioni I. Idiaquez JF, et al. Am J Hypertens. 2021 Mar 11;34(2):125-133. doi: 10.1093/ajh/hpaa131. Am J Hypertens. 2021. PMID: 33705537 Free PMC article. Review.
The development of novel treatments for NOH derives from research in these disorders. We provide a brief review of their underlying pathophysiology relevant to understand the rationale behind treatment options for NOH. The goal of treatment is not to normalize blood …
The development of novel treatments for NOH derives from research in these disorders. We provide a brief review of their underlying p …
Orthostatic hypotension for the cardiologist.
Mar PL, Raj SR. Mar PL, et al. Curr Opin Cardiol. 2018 Jan;33(1):66-72. doi: 10.1097/HCO.0000000000000467. Curr Opin Cardiol. 2018. PMID: 28984649 Free PMC article. Review.
Finally, the United States Food and Drug Administration (FDA) recently approved droxidopa, a synthetic oral norepinephrine prodrug, in 2014 for the treatment of neurogenic orthostatic hypotension (nOH), and it represents a well tolerated, effective, and easy to use interve …
Finally, the United States Food and Drug Administration (FDA) recently approved droxidopa, a synthetic oral norepinephrine prodrug, in 2014 …
Morbidity and mortality in orthostatic hypotension.
Farrell MC, Shibao CA. Farrell MC, et al. Auton Neurosci. 2020 Dec;229:102717. doi: 10.1016/j.autneu.2020.102717. Epub 2020 Aug 17. Auton Neurosci. 2020. PMID: 32896712 Review.
This review summarizes the current literature on the epidemiology of orthostatic hypotension (OH) in the elderly and in patients with autonomic impairment also known as neurogenic OH (nOH); these two conditions have distinct pathophysiologies and affect different patient p …
This review summarizes the current literature on the epidemiology of orthostatic hypotension (OH) in the elderly and in patients with autono …
Supine hypertension: A state of the art.
Mantovani G, Marozzi I, Rafanelli M, Rivasi G, Volpato S, Ungar A. Mantovani G, et al. Auton Neurosci. 2022 Sep;241:102988. doi: 10.1016/j.autneu.2022.102988. Epub 2022 May 14. Auton Neurosci. 2022. PMID: 35613491 Review.
Patients with cardiovascular autonomic failure (AF) may suffer from neurogenic supine hypertension (nSH), defined as systolic blood pressure (SBP) 140 mmHg and/or diastolic blood pressure 90 mmHg, after 5 min of rest in the supine position, combined with neurogenic orthostatic hy …
Patients with cardiovascular autonomic failure (AF) may suffer from neurogenic supine hypertension (nSH), defined as systolic blood pressure …
Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
Isaacson SH, Dashtipour K, Mehdirad AA, Peltier AC. Isaacson SH, et al. Curr Neurol Neurosci Rep. 2021 Mar 9;21(4):18. doi: 10.1007/s11910-021-01104-3. Curr Neurol Neurosci Rep. 2021. PMID: 33687577 Free PMC article. Review.
This article reviews the pathophysiology and clinical characteristics of nOH and nSH, and describes the management of patients with both nOH and nSH. RECENT FINDINGS: Pressor medications required to treat the symptoms of nOH also increase the risk of nSH. Bec …
This article reviews the pathophysiology and clinical characteristics of nOH and nSH, and describes the management of patients with b …
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.
Cutsforth-Gregory JK, Low PA. Cutsforth-Gregory JK, et al. Neurol Ther. 2019 Dec;8(2):307-324. doi: 10.1007/s40120-019-00152-9. Epub 2019 Aug 27. Neurol Ther. 2019. PMID: 31456212 Free PMC article. Review.
Here we review the pathophysiology and effects of the condition as well as treatment considerations for patients with PD and nOH. Screening for nOH using orthostatic symptom questionnaires, orthostatic blood pressure measurements, and specialized autonomic testing i …
Here we review the pathophysiology and effects of the condition as well as treatment considerations for patients with PD and nOH. Scr …
Breathing and Noh: emotional breathing.
Homma I. Homma I. Adv Exp Med Biol. 2010;669:337-40. doi: 10.1007/978-1-4419-5692-7_69. Adv Exp Med Biol. 2010. PMID: 20217378
Dapsone-induced hemolytic anemia.
Jollow DJ, Bradshaw TP, McMillan DC. Jollow DJ, et al. Drug Metab Rev. 1995;27(1-2):107-24. doi: 10.3109/03602539509029818. Drug Metab Rev. 1995. PMID: 7641572 Review.
In studies on rat red cells, we have established that the N-hydroxy metabolites of dapsone, DDS-NOH and MADDS-NOH, are direct-acting hemolytic agents, that they are formed in amounts sufficient to account for the hemotoxicity of the parent drug, and that the action …
In studies on rat red cells, we have established that the N-hydroxy metabolites of dapsone, DDS-NOH and MADDS-NOH, are direct- …
10,607 results
You have reached the last available page of results. Please see the User Guide for more information.